DE2648458C2 - Verfahren zum Nachweis eines im Serum von Krebspatienten vorkommenden, spezifischen Proteins und Reagenz zur Durchführung dieses Verfahrens - Google Patents

Verfahren zum Nachweis eines im Serum von Krebspatienten vorkommenden, spezifischen Proteins und Reagenz zur Durchführung dieses Verfahrens

Info

Publication number
DE2648458C2
DE2648458C2 DE2648458A DE2648458A DE2648458C2 DE 2648458 C2 DE2648458 C2 DE 2648458C2 DE 2648458 A DE2648458 A DE 2648458A DE 2648458 A DE2648458 A DE 2648458A DE 2648458 C2 DE2648458 C2 DE 2648458C2
Authority
DE
Germany
Prior art keywords
protein
salt
reagent
serum
coa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2648458A
Other languages
German (de)
English (en)
Other versions
DE2648458A1 (de
Inventor
Edsel T. Bucovaz
John C. Memphis Tenn. Morrison
William C. Germantown Tenn. Morrison
Walter D. Memphis Tenn. Whybrew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of DE2648458A1 publication Critical patent/DE2648458A1/de
Application granted granted Critical
Publication of DE2648458C2 publication Critical patent/DE2648458C2/de
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE2648458A 1976-09-29 1976-10-26 Verfahren zum Nachweis eines im Serum von Krebspatienten vorkommenden, spezifischen Proteins und Reagenz zur Durchführung dieses Verfahrens Expired DE2648458C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/727,633 US4160817A (en) 1976-09-29 1976-09-29 Application of protein-protein interaction as an assay for the detection of cancer

Publications (2)

Publication Number Publication Date
DE2648458A1 DE2648458A1 (de) 1978-03-30
DE2648458C2 true DE2648458C2 (de) 1982-12-23

Family

ID=24923389

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2648458A Expired DE2648458C2 (de) 1976-09-29 1976-10-26 Verfahren zum Nachweis eines im Serum von Krebspatienten vorkommenden, spezifischen Proteins und Reagenz zur Durchführung dieses Verfahrens

Country Status (7)

Country Link
US (1) US4160817A (cg-RX-API-DMAC10.html)
JP (1) JPS5341421A (cg-RX-API-DMAC10.html)
AU (1) AU512382B2 (cg-RX-API-DMAC10.html)
CA (1) CA1094476A (cg-RX-API-DMAC10.html)
DE (1) DE2648458C2 (cg-RX-API-DMAC10.html)
GB (1) GB1573915A (cg-RX-API-DMAC10.html)
IT (1) IT1077088B (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424278A (en) 1981-11-16 1984-01-03 Research Corporation Cancer detection procedure using an acyl carrier protein

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284552A (en) * 1978-04-26 1981-08-18 Research Corporation Process for the preparation of CoA-SPC from Bakers' yeast
US4261967A (en) * 1978-04-26 1981-04-14 Research Corporation T-factor, CoA-SPC substantially free of proteolytic enzymes and its preparation
US4232001A (en) * 1978-09-22 1980-11-04 University Patents, Inc. Methods and materials for detection of estrophilin
US4241044A (en) * 1978-12-28 1980-12-23 Abbott Laboratories Method of diagnosing cancer by detecting elevated anti-T antibody activity
GB2046902A (en) * 1979-02-20 1980-11-19 Chugai Pharmaceutical Co Ltd Reagents and method for detection of cancer
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
US4368262A (en) * 1981-03-23 1983-01-11 Research Corporation Diagnostic test for the detection of cancer
US4403040A (en) * 1982-02-25 1983-09-06 Aken Morgan D Van Diagnostic test for the detection of a specific tumor antigen with CoA-SPC
JPS58175504U (ja) * 1982-05-19 1983-11-24 コビシ電機株式会社 光スイツチ
US5134662A (en) * 1985-11-04 1992-07-28 Cell Analysis Systems, Inc. Dual color camera microscope and methodology for cell staining and analysis
US5086476A (en) * 1985-11-04 1992-02-04 Cell Analysis Systems, Inc. Method and apparatus for determining a proliferation index of a cell sample
US4998284A (en) * 1987-11-17 1991-03-05 Cell Analysis Systems, Inc. Dual color camera microscope and methodology for cell staining and analysis
US5109429A (en) * 1985-11-04 1992-04-28 Cell Analysis Systems,Inc. Apparatus and method for analyses of biological specimens
JPS63310488A (ja) * 1987-06-12 1988-12-19 米山工業株式会社 住宅用エレベ−タのケ−ジ昇降装置
JPS63310487A (ja) * 1987-06-12 1988-12-19 米山工業株式会社 住宅用エレベ−タ
JPH0772064B2 (ja) * 1989-11-17 1995-08-02 オーチス エレベータ カンパニー エレベーター用鉄塔昇降路
JPH0772066B2 (ja) * 1989-11-17 1995-08-02 オーチス エレベータ カンパニー エレベーター用鉄塔昇降路
JPH0772065B2 (ja) * 1989-11-17 1995-08-02 オーチス エレベータ カンパニー エレベーター用鉄塔昇降路
US6514533B1 (en) * 1992-06-11 2003-02-04 Alkermas Controlled Therapeutics, Inc. Device for the sustained release of aggregation-stabilized, biologically active agent
JPH06206679A (ja) * 1993-01-08 1994-07-26 Kajima Corp 建設資材揚重装置
GB9902659D0 (en) * 1999-02-05 1999-03-31 Microbiological Res Authority Assay with reduced background
US7927612B2 (en) * 2000-01-19 2011-04-19 Baofa Yu Combinations and methods for treating neoplasms
CN101138634A (zh) * 2006-09-07 2008-03-12 于保法 用于治疗肿瘤的组合物
SG11201704175WA (en) 2014-11-26 2017-06-29 Baofa Yu Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424278A (en) 1981-11-16 1984-01-03 Research Corporation Cancer detection procedure using an acyl carrier protein

Also Published As

Publication number Publication date
AU512382B2 (en) 1980-10-09
IT1077088B (it) 1985-04-27
GB1573915A (en) 1980-08-28
JPS5751903B2 (cg-RX-API-DMAC10.html) 1982-11-04
AU1920576A (en) 1978-05-11
CA1094476A (en) 1981-01-27
US4160817A (en) 1979-07-10
DE2648458A1 (de) 1978-03-30
JPS5341421A (en) 1978-04-14

Similar Documents

Publication Publication Date Title
DE2648458C2 (de) Verfahren zum Nachweis eines im Serum von Krebspatienten vorkommenden, spezifischen Proteins und Reagenz zur Durchführung dieses Verfahrens
Amberson Jr et al. A clinical trial of sanocrysin in pulmonary tuberculosis
DE2806146C2 (de) Tumor-spezifisches Glykoprotein und dessen Verwendung zur Krebsdiagnose beim Menschen
DE2548963A1 (de) Verfahren und mittel zur bestimmung der aktivitaet von creatinkinase-mb
Tietz et al. Spectrographic study of trace elements in cancerous and noncancerous human tissues
DE2128670A1 (de) Immunologische Isoenzym Bestimmungs methode
DE69730479T2 (de) Marker und immunologisches Reagens für Dialyse verbundenen Amyloidosis, Diabetes Mellitus und Diabetes Mellitus-Komplikationen
Amies The elementary bodies of zoster and their serological relationship to those of varicella
EP0001223A2 (de) Mit einer Polyhydroxyverbindung beschichteten Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz.
DE60035286T2 (de) Verfahren zum Nachweis von Zelltod mittels Cytochrom C.
Sweeney et al. Effects of chloroquine on patients with cutaneous porphyria of the “symptomatic” type
DE2850950C3 (de) Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
DE3446714A1 (de) Verfahren zum nachweis des vorliegens einer allergie und zum spezifischen nachweis des fuer die allergie verantwortlichen allergens
Bennett et al. Urinary sediment dolichol excretion in patients with Batten disease and other neurodegenerative and storage disorders
DE3147763A1 (de) Nachweisverfahren zur in vitro-bestimmung des bei einer allergie korrespondierenden allergens
DE2333740C2 (de) Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs
Ulrich et al. Immunological reactions in onchocerciasis
US4234476A (en) Application of protein-protein interaction as an assay for the detection of cancer
Friedman et al. Renal excretion of digitoxin in man following oral administration.
Heckly et al. Extraction and fractionation of water-soluble components from tubercle bacilli
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben
Woodhouse The chemodiagnosis of malignancy
DE2606257A1 (de) Recognine
Mohr et al. Lymphocyte-associated antigens in patients with alveolar cell carcinoma
Hernandez Iron content of the brain: Its normal and pathological occurrence

Legal Events

Date Code Title Description
OGA New person/name/address of the applicant
OD Request for examination
D2 Grant after examination
8339 Ceased/non-payment of the annual fee